WHY US
Importance of IRISA™ TB
Extra-pulmonary tuberculosis (EPTB) accounts for 15-20% of all globally reported TB cases.
IRISA™-TB addresses this problem
IRISA™-TB addresses this problem
1.3 million people worldwide die from TB annually. We can treat TB early and save lives!
It is difficult to diagnosis due to low concentrations of bacteria in samples.
Current EPTB diagnostic tests offer sub-optimal sensitivity or specificity. This can lead to mis-or missed diagnosis, which in turn affects patient-associated morbidity and mortality.
IRISA™-TB addresses this problem
The performance of IRISA™-TB has been clinically validated in studies conducted across multiple countries. For example, it is the most accurate diagnostic test for pleural TB, a common form of EPTB.
Delivering high quality products with exceptional quality standards
The value of IRISA™-TB
Simple same day diagnosis of extra-pulmonary tuberculosis. One test that fits all.
IRISA -TB
is designed to rapidly and accurately detect extra-pulmonary TB in several body compartments, including pleural, pericardial, ascitic and cerebrospinal fluid using a clinically validated assay.
It differs from tests using expectorated sputum such as smear microscopy, culture, and nucleic acid amplification tests which all perform poorly in TB of the pleural space, TB abdomen or TB ascites, TB meningitis.
